過敏性鼻炎
B 1 C 4 D 1 U 1
適應症與證據等級
幽門螺旋桿菌 Helicobacter Pylori
B 🟡 B 初步證據 附警語發布 🚨 高市場風險
→
過敏性鼻炎 Allergic Rhinitis
C 🟠 C 薄弱證據 證據分歧 🚨 高市場風險
→
老年免疫 Immune Elderly
C 🟠 C 薄弱證據 附警語發布 🚨 高市場風險
→
腸躁症 Irritable Bowel Syndrome
C 🟠 C 薄弱證據 已發布 🚨 高市場風險
→
異位性皮膚炎 Atopic Dermatitis
C 🟠 C 薄弱證據 附警語發布 🚨 高市場風險
→
濕疹／異位性皮膚炎 Eczema
D 🔴 D 反證據 證據分歧 ✨ 低市場風險
→
感冒（一般上呼吸道感染） Common Cold
U ⚫ U 未驗證 證據不足 🚨 高市場風險
→
法規與權威立場 (L4)
L4a · US FDA
立場：not_addressed
L4b · EU EFSA
立場：against
L4c · UK NHS
立場：not_addressed
There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them. For example, there's no evidence to suggest that probiotics can help treat eczema.
來源 ↗ L4d · TW TFDA / 衛福部
立場：neutral
L4e · WHO
立場：not_addressed
市場與行銷 (L10)
L10a · TW Market Channels
LP33 過敏靈 健字號
L10b · TW Legal Identity (TFDA)
本產品經衛生福利部認證，具有輔助調整過敏體質之保健功效
L10c · TW Community (PTT/Dcard/Mobile01)
對腸胃不錯，鼻子過敏只有一點點，藥遠比LP33顯著